نبذة مختصرة : x ; Medulloblastoma is one of the most common malignant childhood brain tumors. Although advances in multimodal treatment have significantly improved the survival rate, the outcome of children is still very poor. Therefore, there is an urgent need to develop novel approaches that can increase survival and reduce long term side effects of patients. Histone deacetylase inhibitors (HDIs) have emerged as a promising new class of antineoplastic agents in cancer therapy. Among them, suberoylanilide hydroxamic acid (SAHA, vorinostat, Zolinza®) is a highly potential HDI which has been approved for treatment of cutaneous T-cell lymphoma and is currently used for treatment of various tumor cell types both in vivo and in vitro. However, only little information has been reported on the effects of SAHA on primary central nervous system (CNS) tumors including medulloblastoma. The DAOY cell line represents the most widely used model cell line for investigation of medulloblastoma. In a recent study, it was reported that SAHA induces apoptosis and cell cycle arrest of DAOY cells (Sonnemann et al., 2006). However, the molecular mechanisms underlying this antitumor activity are still not clear. Therefore, in this study, effects of SAHA on DAOY cells were analysed at the protein level by using both gel-based and gel-free proteomic approaches. A 2D proteome reference map of DAOY cells in pH range of 4-7 was created from control and 10 µM SAHA treated cells via a combined analysis using 2D electrophoresis and MALDI-TOF/TOF-MS. This reference map covers 1196 identified protein spots of more than 770 distinct proteins. This is the first report of a 2D proteome map of SAHA treated DAOY cells. Moreover, the number of covered proteins was increased with the aid of a 1D-RP-LC-ESI-MS/MS analysis. Both methods together gave rise to a total of over 1200 distinct protein species, which is the largest catalogue of proteins identified in DAOY cells so far. In SAHA treated cells, a series of proteins were found to be subjected to protein ...
No Comments.